688513 Stock Overview
Chengdu Easton Biopharmaceuticals Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Chengdu Easton Biopharmaceuticals Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥32.50 |
| 52 Week High | CN¥46.84 |
| 52 Week Low | CN¥28.11 |
| Beta | 0.077 |
| 11 Month Change | -11.64% |
| 3 Month Change | -5.41% |
| 1 Year Change | -11.94% |
| 33 Year Change | 1.24% |
| 5 Year Change | n/a |
| Change since IPO | -36.06% |
Recent News & Updates
Concerns Surrounding Chengdu Easton Biopharmaceuticals' (SHSE:688513) Performance
Nov 01
There Is A Reason Chengdu Easton Biopharmaceuticals Co., Ltd.'s (SHSE:688513) Price Is Undemanding
Jul 23Recent updates
Concerns Surrounding Chengdu Easton Biopharmaceuticals' (SHSE:688513) Performance
Nov 01There Is A Reason Chengdu Easton Biopharmaceuticals Co., Ltd.'s (SHSE:688513) Price Is Undemanding
Jul 23Why Chengdu Easton Biopharmaceuticals' (SHSE:688513) Shaky Earnings Are Just The Beginning Of Its Problems
May 01Chengdu Easton Biopharmaceuticals Co., Ltd.'s (SHSE:688513) Share Price Matching Investor Opinion
Mar 26Shareholder Returns
| 688513 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -5.7% | -1.5% | -2.1% |
| 1Y | -11.9% | -9.4% | 2.8% |
Return vs Industry: 688513 underperformed the CN Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: 688513 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
| 688513 volatility | |
|---|---|
| 688513 Average Weekly Movement | 6.6% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 688513 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688513's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 1,481 | Mingxu Yuan | www.eastonpharma.cn |
Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry, and urinary system therapeutic categories.
Chengdu Easton Biopharmaceuticals Co., Ltd. Fundamentals Summary
| 688513 fundamental statistics | |
|---|---|
| Market cap | CN¥5.66b |
| Earnings (TTM) | CN¥249.88m |
| Revenue (TTM) | CN¥1.31b |
22.7x
P/E Ratio4.3x
P/S RatioIs 688513 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688513 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.31b |
| Cost of Revenue | CN¥300.48m |
| Gross Profit | CN¥1.01b |
| Other Expenses | CN¥756.92m |
| Earnings | CN¥249.88m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.43 |
| Gross Margin | 77.02% |
| Net Profit Margin | 19.11% |
| Debt/Equity Ratio | 6.2% |
How did 688513 perform over the long term?
See historical performance and comparison